Reklāma
Ginkgo Bioworks Acquires Biotechnology Company Circularis For Undisclosed Terms
(RTTNews) - Ginkgo Bioworks (DNA), the leading horizontal platform for cell programming, announced Tuesday the tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.
When circularized, RNA is much longer-lived in cells, improving its robustness as a potential therapeutic modality. The Circularis platform also allows ultra-high-throughput screening of promoters and other enhancers.
The Circularis platform strengthens Ginkgo's platform for development of cell and gene therapies, providing the capability to rapidly identify novel promoters with appropriate strength and tissue-specificity designed into customer specific delivery modalities.
read more
Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets
Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
RTTNews
|
334 days ago
Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins
Israeli-based foodtech company Imagindairy and Ginkgo Bioworks (DNA) announced Tuesday a new partnership with the aim to deliver a global solution for animal-free non-whey dairy protein production in a highly cost-effective manner.
RTTNews
|
349 days ago
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges
Ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference later on Wednesday, Ginkgo Bioworks (DNA) said it expects to meet its previously disclosed new program and revenue guidance ranges in 2023, based on its preliminary unaudited estimates.
RTTNews
|
425 days ago
Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products
Brazilian agricultural biologicals company Agrivalle announced Friday a new partnership with Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity.
RTTNews
|
458 days ago
NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides
Infant nutrition company NAMUH and Ginkgo Bioworks Holdings, Inc. (DNA) announced Wednesday a multi-product collaboration to develop functional oligosaccharides that are structurally identical to those found in human breast milk.
RTTNews
|
783 days ago
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal
Cell programming firm Ginkgo Bioworks Holdings, Inc. (DNA) and biotechnology company Zymergen, Inc. (ZY) announced Monday they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
RTTNews
|
959 days ago
European Shares Seen Tad Higher At Open
European stocks look set to open a tad higher on Tuesday after falling sharply in the previous session.
RTTNews
|
5h 45min ago
Sensex, Nifty Decline On Growth Worries; IndusInd Bank And IT Stocks Hit Hard
Indian shares were subdued on Tuesday on concerns about U.S. President Donald Trump's flip-flop tariff policy and its impact on inflation, interest rates and global growth.
RTTNews
|
6h 54min ago
